Recent studies have identified novel functional roles for the basic leucine zipper transcription factor CCAAT/enhancer binding protein-beta (C/EBPb) in cell survival and tumor development;however, the molecular mechanisms through which C/EBPb regulates these processes are poorly understood. C/EBPb-/- mice are completely refractory to skin tumor development induced by carcinogens that produce tumors with oncogenic Ras mutations. In response to topical carcinogen treatment, C/EBPb-/- mice display a 17-fold increase in keratinocyte apoptosis compared to wild type mice. This abnormal increase in apoptosis in C/EBPb-/- mice requires p53 and is due to aberrant up-regulation of p53 protein. We hypothesize that C/EBPb mediates the survival of initiated tumor precursor cells through the repression of p53 and that the consequences of C/EBPb deficiency are de-repression of p53, p53-mediated tumor precursor cell apoptosis and ablation of tumorigenesis. Understanding the pro-apoptotic response in C/EBPb-/- mice has important implications for tumor development. Exactly how C/EBPb represses p53 levels and whether this repression occurs in response to DNA damage and/or Ras-induced oncogenic stress is not known. If C/EBPb is critical for oncogenic Ras tumor cell survival then blocking C/EBPb function in a p53-proficient oncogenic Ras-containing tumor should result in tumor cell apoptosis and tumor regression, thus we propose that C/EBPb has potential as a molecular target for cancer therapy. The goals of this proposal are: 1) to determine how C/EBPb represses p53/apoptosis and determine whether this repression occurs in response to DNA damage and/or oncogenic Ras;2) to determine whether repression of p53 by C/EBPb is critical for tumorigenesis;3) determine the importance of Ras and/or DNA damage-induced C/EBPb post-translation modifications in vivo;and 4) to determine whether C/EBPb is a potential molecular target for tumor regression. The long-term objectives of this proposal are to understand the molecular mechanisms through which C/EBPb influences the neoplastic process in epithelia and regulates tumor cell survival.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA046637-19
Application #
8064805
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Johnson, Ronald L
Project Start
1990-05-01
Project End
2014-05-31
Budget Start
2011-06-01
Budget End
2014-05-31
Support Year
19
Fiscal Year
2011
Total Cost
$249,141
Indirect Cost
Name
North Carolina State University Raleigh
Department
Public Health & Prev Medicine
Type
Schools of Earth Sciences/Natur
DUNS #
042092122
City
Raleigh
State
NC
Country
United States
Zip Code
27695
Messenger, Zachary J; Hall, Jonathan R; Jima, Dereje D et al. (2018) C/EBP? deletion in oncogenic Ras skin tumors is a synthetic lethal event. Cell Death Dis 9:1054
Hall, Jonathan R; Bereman, Michael S; Nepomuceno, Angelito I et al. (2014) C/EBP? regulates CRL4(Cdt2)-mediated degradation of p21 in response to UVB-induced DNA damage to control the G1/S checkpoint. Cell Cycle 13:3602-10
Thompson, Elizabeth A; Zhu, Songyun; Hall, Jonathan R et al. (2011) C/EBPýý expression is downregulated in human nonmelanoma skin cancers and inactivation of C/EBPýý confers susceptibility to UVB-induced skin squamous cell carcinomas. J Invest Dermatol 131:1339-46
Lee, Sook; Shuman, Jon D; Guszczynski, Tad et al. (2010) RSK-mediated phosphorylation in the C/EBP{beta} leucine zipper regulates DNA binding, dimerization, and growth arrest activity. Mol Cell Biol 30:2621-35
Kim, Tae-Hyung; Chiera, Shannon L; Linder, Keith E et al. (2010) Overexpression of transcription factor sp2 inhibits epidermal differentiation and increases susceptibility to wound- and carcinogen-induced tumorigenesis. Cancer Res 70:8507-16
House, John S; Zhu, Songyun; Ranjan, Rakesh et al. (2010) C/EBPalpha and C/EBPbeta are required for Sebocyte differentiation and stratified squamous differentiation in adult mouse skin. PLoS One 5:e9837
Omori, Emily; Matsumoto, Kunihiro; Zhu, Songyun et al. (2010) Ablation of TAK1 upregulates reactive oxygen species and selectively kills tumor cells. Cancer Res 70:8417-25
Ranjan, R; Thompson, E A; Yoon, K et al. (2009) C/EBPalpha expression is partially regulated by C/EBPbeta in response to DNA damage and C/EBPalpha-deficient fibroblasts display an impaired G1 checkpoint. Oncogene 28:3235-45